{"url_path":"/sec/traw/8-k/2026-06-12/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-12","source_url":"https://www.sec.gov/Archives/edgar/data/1130598/0001104659-26-073593-index.html","accession_number":"0001104659-26-073593","cik":"0001130598","ticker":"TRAW","issuer_name":"Traws Pharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1130598/0001104659-26-073593-index.html","primary_entity_key":"0001130598","primary_entity_name":"Traws Pharma, Inc."},"word_count":79,"has_tables":true,"body_markdown":"**Item 9.01 Financial\nStatements and Exhibits.**\n\n \n\n(d) Exhibits.\n\n \n\n**Exhibit No.**\n \n**Description**\n\n[99.1](tm2617872d1_ex99-1.htm)\n \n[Press Release, dated June 12, 2026.](tm2617872d1_ex99-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded\nwithin the inline XBRL Document)\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its\nbehalf by the undersigned hereunto duly authorized.\n\n \n\nDate: June 12, 2026\n**TRAWS PHARMA, INC.**\n\n \n \n \n\n \nBy:\n/s/ Charles Parker\n\n \n \nCharles Parker\n\n \n \nChief Financial Officer"}